JiangSu DaLong Pharmaceutical Technology Co., Ltd.-Digestive system medication, biological agents, traditional Chinese medicine drinks

Company Profile

To become a diversified pharmaceutical and healthcare group integrating licensed retailing, scientific research, manufacturing, imports and exports

JiangSu DaLong Pharmaceutical Technology Co., Ltd is located in the ancient capital of China's six dynasties, Nanjing, JiangSu Province.
The product portfolio covers grounds in anti-infectives, digestive system drugs, neurotrophic agents, biologics, emergency medicine, neuropsychiatric system medicine, ethnic medicine and Traditional Chinese Medicine (TCM) decoction pieces.

about us

2017
founding
20+
Collaborated generics development
2000+
Tertiary hospitals
8Years
sales personnel experience
800Million Yuan
Overall revenue of 2022

business scope

Production

Anhui Ailikang Pharmaceutical Manufacturing Co., Ltd is wholly owned by JiangSu DaLong Pharmaceutical Technology Co., Ltd. Covering an area of over 30 acres, it will have multiple production lines for human medicine and veterinary medicine and will be mainly responsible for the production of chemical drugs, Traditional Chinese Medicine (TCM) and traditional Chinese medicine decoction pieces after completion later this year.

business scope

Our Sales

Our pharmaceutical sales are based in Jiangsu Province, covering the whole country, with both direct retailing and licensed agents, present in 2000 tertiary hospitals nationwide. There are over 200 personnel in the sales team, 60 among whom are full-time sales representatives responsible for marketing. The team is ever expanding.

business scope

Registration and Imports

JiangSu DaLong Pharmaceutical Technology Co., Ltd. jointly developed a dozen of generics with Nanjing Huawe Medicine Technology Group Co., Ltd and performs the registraton of domestic and imported drugs in collaboration.

Production
Our Sales
Registration and Imports

Our Portfolio

Medicines under National Essential Medicines List &
National Reimbursement Drug list

The product portfolio covers grounds in anti-infectives, digestive system drugs, neurotrophic agents, biologics, emergency medicine, neuropsychiatric system medicine, ethnic medicine and traditional Chinese medicine (TCM) decoction pieces.

View Products

Media Express

Latest News

View All

Market situation

A diversified pharmaceutical
and health industry group

Ever-expanding product porfolio
Research & development together with licensed marketing
A sales network nationwide with rich resources
Increasing turnover over the years, overall revenue hit 800 million Chinese RMB in 2022
Partnerships with enterprises from home and abroad

A diversified pharmaceutical
and healthcare group

Collaborating with multiple
domestic and foreign companies in

Located in the ancient capital
of China's six dynasties